Immunohistochemical detection of the delayed formation of nonfibrillar large amyloid‐β aggregates
Open Access
- 25 January 2016
- journal article
- research article
- Published by Wiley in Genes to Cells
- Vol. 21 (2) , 200-211
Abstract
The occurrence of senile plaques consisting of amyloid‐β protein (Aβ) is a major neuropathological hallmark of Alzheimer's disease (AD). We previously developed and characterized monoclonal antibodies 31‐2 and 75‐2 that specifically bind to nonfibrillar Aβ1–42 aggregates with diameters of more than 220 and 50 nm, respectively. Here, we report the use of these antibodies to examine the aggregation of exogenous Aβ1–42 in cultured rat hippocampal neurons. From 6 to 24 h after transfection of Aβ1–42, antibody 75‐2 immunolabeled almost all transfected neurons, whereas 31‐2‐positive cells were restricted to a part of the transfected neurons and gradually increased in number. Expression of the F19S/L34P‐mutant Aβ1–42, which showed less of a tendency to aggregate, resulted in clearly reduced immunoreactivity to both antibodies. We also immunohistochemically investigated the temporal cortices of patients with AD and found that 31‐2 preferentially labeled the cores of a subpopulation of large amyloid plaques. The relative number of 31‐2‐immunoreactive plaques was found to correlate with the Braak stages of neurofibrillary tangles, but not with that of amyloid plaques. These results suggest that 31‐2‐reactive Aβ aggregates develop with a delayed time course in cultured neurons and amyloid plaques of AD brains.Keywords
This publication has 25 references indexed in Scilit:
- Age‐related modulation of γ‐secretase activity in non‐human primate brainsJournal of Neurochemistry, 2012
- Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratioThe EMBO Journal, 2010
- A new amyloid β variant favoring oligomerization in Alzheimer's‐type dementiaAnnals of Neurology, 2008
- Intracellular amyloid-β in Alzheimer's diseaseNature Reviews Neuroscience, 2007
- Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairmentNeurology, 2007
- Inhibitor Discovery Targeting the Intermediate Structure of β-Amyloid Peptide on the Conformational Transition Pathway: Implications in the Aggregation Mechanism of β-Amyloid PeptideBiochemistry, 2006
- Mutations that Reduce Aggregation of the Alzheimer's Aβ42 Peptide: an Unbiased Search for the Sequence Determinants of Aβ AmyloidogenesisJournal of Molecular Biology, 2002
- The Oligomerization of Amyloid β-Protein Begins Intracellularly in Cells Derived from Human BrainBiochemistry, 2000
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991